Expression of Metabolic Syndrome in Women with Severe Obesity.

BACKGROUND The prevalence of metabolic syndrome (MetS) generally rises with increasing adiposity, but tends to plateau at the highest levels of body mass index (BMI) with some individuals, even with severe obesity, expressing few or no components of MetS. We examined factors associated with the expression of MetS in severely obese women participating in a large observational study. METHODS Anthropometrics, including Heath equation-adjusted bioimpedance-determined fat-free mass (FFM) and fat mass (FM), lipids and related laboratory measurements, resting energy expenditure (REE), and respiratory quotient (RQ), were studied in 949 women with severe obesity. RESULTS Even though the mean BMI was 45.7 kg/m2 and all participants met MetS criteria for increased waist circumference, 30% of subjects did not have MetS. Unadjusted FM (P = 0.0011), FFM (P < 0.0001), and REE (P < 0.0001) were greater in the women with MetS. Surprisingly, in multivariate logistic regression FFM was positively associated with MetS (P = 0.0002), while FM was not (P = 0.89). Moreover, FFM, not FM, was significantly associated with all five components of MetS except for triglyceride levels. REE and RQ were higher in those with MetS, and REE was strongly associated with multiple components of MetS. CONCLUSIONS In women with severe obesity, higher FFM and REE were paradoxically associated with increased rather than decreased risk of MetS, while FFM-adjusted FM was unrelated to MetS.

[1]  R. Ross,et al.  Abdominal Adiposity, Not Cardiorespiratory Fitness, Mediates the Exercise-Induced Change in Insulin Sensitivity in Older Adults , 2016, PloS one.

[2]  E. Heggen,et al.  Characteristics of Metabolic Syndrome in Morbidly Obese Subjects. , 2016, Metabolic syndrome and related disorders.

[3]  M. Jensen,et al.  Does basal metabolic rate predict weight gain? , 2016, The American journal of clinical nutrition.

[4]  H. Dopazo,et al.  Serum aminotransferases in nonalcoholic fatty liver disease are a signature of liver metabolic perturbations at the amino acid and Krebs cycle level. , 2016, The American journal of clinical nutrition.

[5]  M. Surani,et al.  Trim28 Haploinsufficiency Triggers Bi-stable Epigenetic Obesity , 2016, Cell.

[6]  J. Moreno-Navarrete,et al.  Lean mass, and not fat mass, is an independent determinant of carotid intima media thickness in obese subjects. , 2015, Atherosclerosis.

[7]  Owen Carmichael,et al.  Emerging Technologies and their Applications in Lipid Compartment Measurement , 2015, Trends in Endocrinology & Metabolism.

[8]  S. Dooley,et al.  Xanthine oxidase in non-alcoholic fatty liver disease and hyperuricemia: One stone hits two birds. , 2015, Journal of hepatology.

[9]  J. Pedraza-Chaverri,et al.  Renal Oxidative Stress Induced by Long-Term Hyperuricemia Alters Mitochondrial Function and Maintains Systemic Hypertension , 2015, Oxidative medicine and cellular longevity.

[10]  P. Scherer,et al.  The cell biology of fat expansion , 2015, The Journal of cell biology.

[11]  S. Klein,et al.  Metabolically normal obese people are protected from adverse effects following weight gain. , 2015, The Journal of clinical investigation.

[12]  C. Calhau,et al.  Beyond central adiposity: liver fat and visceral fat area are associated with metabolic syndrome in morbidly obese patients. , 2015, International journal of surgery.

[13]  Melissa J. Morine,et al.  Monounsaturated Fatty Acid–Enriched High-Fat Diets Impede Adipose NLRP3 Inflammasome–Mediated IL-1β Secretion and Insulin Resistance Despite Obesity , 2015, Diabetes.

[14]  C. Bogardus,et al.  Fasting hyperglycemia predicts lower rates of weight gain by increased energy expenditure and fat oxidation rate. , 2015, The Journal of clinical endocrinology and metabolism.

[15]  Charles A McKenzie,et al.  Validation of volumetric and single‐slice MRI adipose analysis using a novel fully automated segmentation method , 2015, Journal of magnetic resonance imaging : JMRI.

[16]  K. Cusi,et al.  The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease , 2015, Hepatology.

[17]  B. Eliasson,et al.  Adipocyte Hypertrophy, Inflammation and Fibrosis Characterize Subcutaneous Adipose Tissue of Healthy, Non-Obese Subjects Predisposed to Type 2 Diabetes , 2014, PloS one.

[18]  Eric J. Brunner,et al.  Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study , 2014, European heart journal.

[19]  G. Hunter,et al.  Resting Energy Expenditure and Systolic Blood Pressure Relationships in Women Across 4.5 Years , 2014, Journal of clinical hypertension.

[20]  O. P. Faria,et al.  Validation Study of Multi-Frequency Bioelectrical Impedance with Dual-Energy X-ray Absorptiometry Among Obese Patients , 2014, Obesity Surgery.

[21]  J. Thornton,et al.  Validity of Bioelectrical Impedance Analysis for Measuring Changes in Body Water and Percent Fat After Bariatric Surgery , 2014, Obesity Surgery.

[22]  U. Smith,et al.  Restricted Adipogenesis in Hypertrophic Obesity , 2013, Diabetes.

[23]  Kai Huang,et al.  High Serum Uric Acid and Increased Risk of Type 2 Diabetes: A Systemic Review and Meta-Analysis of Prospective Cohort Studies , 2013, PloS one.

[24]  R. Ross,et al.  Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver fat, and cardiometabolic risk profile: the International Study of Prediction of Intra-Abdominal Adiposity and Its Relationship With Cardiometabolic Risk/Intra-Abdominal Adiposity. , 2012, The American journal of clinical nutrition.

[25]  Peter Stenvinkel,et al.  Redefining Metabolic Syndrome as a Fat Storage Condition Based on Studies of Comparative Physiology , 2012, Obesity.

[26]  J. Kullberg,et al.  Comparison of Gross Body Fat-Water Magnetic Resonance Imaging at 3 Tesla to Dual Energy X-Ray Absorptiometry in Obese Women , 2012, Obesity.

[27]  H. Bays Adiposopathy is "sick fat" a cardiovascular disease? , 2011, Journal of the American College of Cardiology.

[28]  P. Scherer,et al.  Adipose tissue remodeling and obesity. , 2011, The Journal of clinical investigation.

[29]  F. Buttgereit,et al.  Energy regulation and neuroendocrine–immune control in chronic inflammatory diseases , 2010, Journal of internal medicine.

[30]  M. Reilly,et al.  Adipocyte Modulation of High-Density Lipoprotein Cholesterol , 2010, Circulation.

[31]  J. Schold,et al.  Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response , 2010, International Journal of Obesity.

[32]  A. Colao,et al.  Validity of Bioelectrical Impedance Analysis to Estimate Body Composition Changes After Bariatric Surgery in Premenopausal Morbidly Women , 2010, Obesity surgery.

[33]  W. Rosamond,et al.  Health Outcomes of Gastric Bypass Patients Compared to Nonsurgical, Nonintervened Severely Obese , 2010, Obesity.

[34]  S. Grundy,et al.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International As , 2009, Circulation.

[35]  K. Reynolds,et al.  The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). , 2008, Archives of internal medicine.

[36]  M. Gagner,et al.  Bioimpedance for Severe Obesity: Comparing Research Methods for Total Body Water and Resting Energy Expenditure , 2008, Obesity.

[37]  M. Mathieu,et al.  Contribution of the Lean Body Mass to Insulin Resistance in Postmenopausal Women With Visceral Obesity: A Monet Study , 2008, Obesity.

[38]  S. Buscemi,et al.  A low resting metabolic rate is associated with metabolic syndrome. , 2007, Clinical nutrition.

[39]  D. McKenzie,et al.  Endogenous androgen levels and cardiovascular risk profile in women across the adult life span , 2007, Menopause.

[40]  S. Grandy,et al.  The relationship of body mass index to diabetes mellitus, hypertension and dyslipidaemia: comparison of data from two national surveys , 2007, International journal of clinical practice.

[41]  M. Shibata,et al.  Estimating oxygen consumption rates of arteriolar walls under physiological conditions in rat skeletal muscle. , 2005, American journal of physiology. Heart and circulatory physiology.

[42]  B. Nicklas,et al.  The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. , 2004, The Journal of clinical endocrinology and metabolism.

[43]  K. Holdy Monitoring energy metabolism with indirect calorimetry: instruments, interpretation, and clinical application. , 2004, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[44]  S. Hunt,et al.  Bioelectric impedance and hydrostatic weighing with and without head submersion in persons who are morbidly obese. , 1998, Journal of the American Dietetic Association.

[45]  E. Ravussin,et al.  Metabolic predictors of obesity: cross-sectional versus longitudinal data. , 1993, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[46]  S. Hosoda,et al.  Accelerated purine nucleotide degradation by anaerobic but not by aerobic ergometer muscle exercise. , 1992, Metabolism: clinical and experimental.

[47]  J. Lalouel,et al.  A rapid micro-scale procedure for determination of the total lipid profile. , 1989, Clinical chemistry.

[48]  Hasday Jd,et al.  Nocturnal increase of urinary uric acid:creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. , 1987 .

[49]  Krishna S Nayak,et al.  Quantification of Absolute Fat Mass by Magnetic Resonance Imaging: a Validation Study against Chemical Analysis. , 2011, International journal of body composition research.